How well did the RSV vaccine work?

Across all older adults in the trial, it clearly reduced hospital stays for RSV lung disease.

Who was most at risk from RSV?

Older adults with weakened immunity. Without the vaccine, they were hospitalized with RSV many times more often than those with typical immunity.

Did the vaccine work for people with weakened immunity?

Yes. It protected them, and because their risk is so much higher, the vaccine could prevent more hospital stays for them.

How many doses did people get?

A single dose of the vaccine, given in November or December 2024.

RSV vaccine cut hospital stays in adults 60 and up, a win against infections

By Mongevity Desk Published Nov. 3, 2026, 5:18 pm

Infections and vaccines after 50Part of a story we are following · 6 articles · See every update

RSV vaccine cut hospital stays in adults 60 and up, a win against infections

If you or someone you love is 60 or older, there is good news about winter infections. A large trial in Denmark found that a single RSV vaccine shot kept older adults out of the hospital. That includes people whose immune systems are weaker, who face the highest risk from this virus.

RSV, short for respiratory syncytial virus, can cause serious lung infections in older adults. This is a shot worth telling your parents about, and anyone you know with lowered defenses.

How the study worked

In November and December 2024, researchers in Denmark randomly assigned a large group of adults aged 60 or older to one dose of an RSV vaccine or to no vaccine. About 5,199 of them had a weakened immune system, meaning they had been seen in a hospital for an immune-weakening condition or treatment. The team followed hospital records until May 31, 2025, and published the results on October 6, 2026 in The Lancet Healthy Longevity. The trial was supported by Pfizer, and only 21 people in all were hospitalized with RSV, so the group comparisons are early numbers that larger studies will sharpen.

What they found

Across everyone in the trial, the vaccine clearly cut hospital stays for RSV lung disease. In plain terms, the vaccinated group had far fewer people end up in the hospital with RSV than the group that got no shot.

The risk was not the same for everyone. Among people who did not get the vaccine, those with weakened immunity were hospitalized with RSV many times more often than those with typical immunity.

That is why the vaccine matters so much for this group. The vaccine protected people with weakened immunity, and it protected people with typical immunity even more strongly. But because the starting risk is so much higher with weakened immunity, each shot can prevent more hospital stays there.

The researchers say that prioritizing RSV vaccination for people with weakened immunity could bring real benefits, and that these results could help guide vaccine policy.

What counts as weakened immunity?

In this study, it meant at least one hospital visit for a condition or treatment that weakens the immune system. Your own doctor knows whether that describes you or a family member, and that is the person to ask.

What you can do today

Call your doctor’s office or your pharmacy and ask whether an RSV vaccine is right for you, or for a parent or relative who is 60 or older. If anyone in the family takes medicines that weaken the immune system, mention that. It takes a couple of minutes, and you may leave the call with an appointment for a shot that can keep someone you love out of the hospital this winter.

Talk about it at home

RSV is a virus that can make people’s lungs very sick, especially grandparents. A vaccine teaches the body to spot the virus early, so it can fight back fast. In this trial, researchers let chance decide who got the shot and who did not, and then counted who ended up in the hospital.

Question for the table

Here is a question for the table: why do you think the researchers let chance pick who got the vaccine, instead of letting people choose?

Keep exploring

Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.

I read this Mongevity article and want to keep learning with my family. Explain it to us in plain language, suggest safe ideas we can try at home, and tell us if anything should be checked with a doctor. This is not medical advice.

{
    "titulo": "RSV vaccine cut hospital stays in adults 60 and up, a win against infections",
    "url": "https://mongevity.science/immunity/2026/11/rsv-vaccine-older-adults-fewer-hospital-stays/",
    "estudio": {
        "tipo": "randomized trial",
        "revista": "The Lancet Healthy Longevity",
        "fecha": "2026-10-06",
        "doi": "https://doi.org/10.1016/j.lanhl.2026.100895"
    },
    "hallazgo": "A large Danish trial of adults 60 and up found the RSV vaccine cut hospital stays for RSV lung disease. Share it with your parents and anyone with weaker defenses.",
    "que_puedo_hacer": "Call your doctor's office or pharmacy and ask whether an RSV vaccine is right for you or for a parent who is 60 or older.",
    "preguntas": [
        "Here is a question for the table: why do you think the researchers let chance pick who got the vaccine, instead of letting people choose?"
    ]
}

Questions and answers

How well did the RSV vaccine work?: Across all older adults in the trial, it clearly reduced hospital stays for RSV lung disease.
Who was most at risk from RSV?: Older adults with weakened immunity. Without the vaccine, they were hospitalized with RSV many times more often than those with typical immunity.
Did the vaccine work for people with weakened immunity?: Yes. It protected them, and because their risk is so much higher, the vaccine could prevent more hospital stays for them.
How many doses did people get?: A single dose of the vaccine, given in November or December 2024.